Edgewise Therapeutics (EWTX) Short Interest Ratio & Short Volume → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free EWTX Stock Alerts $20.00 -0.89 (-4.26%) (As of 05/9/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Edgewise Therapeutics Short Interest DataCurrent Short Volume5,760,000 sharesPrevious Short Volume5,720,000 sharesChange Vs. Previous Month+0.70%Dollar Volume Sold Short$94.92 millionShort Interest Ratio / Days to Cover7.6Last Record DateApril 15, 2024Outstanding Shares93,110,000 sharesFloat Size62,970,000 sharesShort Percent of Float9.15%Today's Trading Volume1,026,343 sharesAverage Trading Volume900,873 sharesToday's Volume Vs. Average114% Short Selling Edgewise Therapeutics ? Sign up to receive the latest short interest report for Edgewise Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatEWTX Short Interest Over TimeEWTX Days to Cover Over TimeEWTX Percentage of Float Shorted Over Time Ad InvestorPlaceProof that the Musk/Bezos rivalry is about to hit a new levelElon Musk Humiliated Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats…Go here now for full story. Edgewise Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20245,760,000 shares $94.92 million +0.7%9.2%7.6 $16.48 3/31/20245,720,000 shares $104.33 million +27.7%9.1%5.7 $18.24 3/15/20244,480,000 shares $75.80 million -18.0%7.1%4.3 $16.92 2/29/20245,460,000 shares $89.16 million +6.4%9.1%5.6 $16.33 2/15/20245,130,000 shares $93.98 million -5.0%8.6%5.4 $18.32 1/31/20245,400,000 shares $96.28 million -33.9%11.5%6.3 $17.83 Get the Latest News and Ratings for EWTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Edgewise Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20248,170,000 shares $81.70 million -12.5%22.7%10.8 $10.00 12/31/20239,340,000 shares $102.18 million +9.9%25.9%20.1 $10.94 12/15/20238,500,000 shares $61.97 million +20.9%23.7%22.6 $7.29 11/30/20237,030,000 shares $42.74 million +11.1%19.6%24.7 $6.08 11/15/20236,330,000 shares $41.52 million +5.3%17.7%34.2 $6.56 10/31/20236,010,000 shares $38.46 million +4.5%17.0%35.9 $6.40 10/15/20235,750,000 shares $38.58 million +1.6%16.3%36.2 $6.71 9/30/20235,660,000 shares $32.43 million +2.2%16.1%33.2 $5.73 9/15/20235,540,000 shares $35.57 million +1.7%15.7%28.2 $6.42 8/31/20235,450,000 shares $34.06 million +1.1%13.9%26.9 $6.25 8/15/20235,390,000 shares $39.35 million -1.3%13.8%24.5 $7.30 7/31/20235,460,000 shares $39.80 million -12.1%13.7%24.8 $7.29 7/15/20236,210,000 shares $44.84 million +11.7%15.6%27.4 $7.22 6/30/20235,560,000 shares $43.09 million +3.5%14.0%26.4 $7.75 6/15/20235,370,000 shares $46.83 million +12.6%13.5%25 $8.72 5/31/20234,770,000 shares $48.27 million +5.8%12.0%25.3 $10.12 5/15/20234,510,000 shares $40.68 million +1.8%11.3%25.8 $9.02 4/30/20234,430,000 shares $38.85 million +6.2%11.0%25.6 $8.77 4/15/20234,170,000 shares $24.23 million +4.5%10.3%26.5 $5.81 3/31/20233,990,000 shares $26.61 million +6.1%9.9%25.1 $6.67 3/15/20233,760,000 shares $28.76 million -2.1%9.3%25.4 $7.65 2/28/20233,840,000 shares $36.79 million +1.6%9.5%22.4 $9.58 2/15/20233,780,000 shares $37.76 million -2.3%9.3%21.3 $9.99 1/31/20233,870,000 shares $39.59 million +29.9%9.6%21.5 $10.23 1/15/20232,980,000 shares $32.93 million -25.7%7.4%15.8 $11.05 12/30/20224,010,000 shares $35.85 million +38.8%10.0%20 $8.94 12/15/20222,890,000 shares $22.46 million -16.2%7.2%13.3 $7.77 11/30/20223,450,000 shares $30.88 million -3.1%8.6%11.8 $8.95 11/15/20223,560,000 shares $37.38 million -1.1%8.9%12 $10.50 10/31/20223,600,000 shares $34.24 million +8.4%8.9%12.1 $9.51 10/15/20223,320,000 shares $34.59 million +19.0%10.4%10.9 $10.42 9/30/20222,790,000 shares $27.45 million +5.3%10.2%9.2 $9.84 9/15/20222,650,000 shares $24.19 million -12.3%9.7%8.3 $9.13 8/31/20223,020,000 shares $30.44 million -17.0%10.8%12.3 $10.08READ THIS – If You Missed Out On The AI Boom (Ad)Adam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. EWTX Short Interest - Frequently Asked Questions What is Edgewise Therapeutics' current short interest? Short interest is the volume of Edgewise Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 5,760,000 shares of EWTX short. 9.15% of Edgewise Therapeutics' shares are currently sold short. Learn More on Edgewise Therapeutics' current short interest. What is a good short interest ratio for Edgewise Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EWTX shares currently have a short interest ratio of 8.0. Learn More on Edgewise Therapeutics's short interest ratio. What is a good short interest percentage for Edgewise Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.15% of Edgewise Therapeutics' floating shares are currently sold short. Is Edgewise Therapeutics' short interest increasing or decreasing? Edgewise Therapeutics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 5,760,000 shares, an increase of 0.7% from the previous total of 5,720,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Edgewise Therapeutics' float size? Edgewise Therapeutics currently has issued a total of 93,110,000 shares. Some of Edgewise Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Edgewise Therapeutics currently has a public float of 62,970,000 shares. How does Edgewise Therapeutics' short interest compare to its competitors? 9.15% of Edgewise Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Edgewise Therapeutics: Syndax Pharmaceuticals, Inc. (11.30%), Amneal Pharmaceuticals, Inc. (2.51%), NewAmsterdam Pharma (0.85%), Galapagos NV (2.30%), Amphastar Pharmaceuticals, Inc. (11.01%), Deciphera Pharmaceuticals, Inc. (11.45%), Agios Pharmaceuticals, Inc. (12.15%), Structure Therapeutics Inc. (9.92%), Keros Therapeutics, Inc. (6.27%), Rocket Pharmaceuticals, Inc. (12.12%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Edgewise Therapeutics stock? Short selling EWTX is an investing strategy that aims to generate trading profit from Edgewise Therapeutics as its price is falling. EWTX shares are trading down $0.89 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Edgewise Therapeutics? A short squeeze for Edgewise Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EWTX, which in turn drives the price of the stock up even further. How often is Edgewise Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EWTX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Syndax Pharmaceuticals Short Squeeze Amneal Pharmaceuticals Short Squeeze NewAmsterdam Pharma Short Squeeze Galapagos Short Squeeze Amphastar Pharmaceuticals Short Squeeze Deciphera Pharmaceuticals Short Squeeze Agios Pharmaceuticals Short Squeeze Structure Therapeutics Short Squeeze Keros Therapeutics Short Squeeze Rocket Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EWTX) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsGold ManiaStansberry Research